OUR APPROACH

Engineered, not copied.

A virus is not a single, fixed target but a family of related variants that keeps changing. Our platform combines machine learning, structural biology and evolutionary analysis to read how a viral family has evolved, then engineers a new antigen around what its members share.

HOW IT WORKS

How We Engineer Our Antigens

Our platform generates vaccine candidates that preserve the essential genetic and structural characteristics shared across a clade, lineage, or entire viral family

  • Antigen backbones computationally engineered for broad protection
  • Immune optimized antigens increase cross-reactivity, enabling protection against both known variants and potential future strains
  • Multiple DVX antigens can be combined to create robust multi-variant or multi-valent vaccines
  • DVX antigens validated in vivo, with superior preclinical performance vs. standard seasonal vaccines

THE AI LAYER

AI-based Computational Platform

From the full sequence history of a viral family to a short list of designed antigens, in silico.

  • Bench work, done computationally: the screening that used to take iterative rounds at the bench is done before anything is expressed.
  • Multi-criteria ranking: candidates are ranked on conservation, structural plausibility and predicted antibody engagement together, not on one criterion.
  • One pipeline, any family: the same pipeline runs on any viral family; it is a platform, not a single product.

ANTIGEN DESIGN

Engineering The Antigen Backbone

Targeted modifications that turn an evolutionary backbone into the final DVX antigen.

What the modifications are for:

  • Broader immune recognition
  • Structural stability
  • Controlled epitope exposure
  • Expressible at scale

AT A GLANCE

What changes with DIOSynVax

Discover how DIOSynVax’s approach differs from conventional vaccine design. Hover or tap each card to explore.

1

Design input

WHAT MOST VACCINES DO

One circulating viral strain.

↻   Flip for the DIOSynVax approach

1

Design input

WHAT DIOSYNVAX DOES

The evolutionary history of a clade, lineage or family.

WHY IT MATTERS

The antigen represents the family, not one member.

↻   Flip back

2

The antigen

WHAT MOST VACCINES DO

Copies the antigen sequence of that strain.

↻   Flip for the DIOSynVax approach

2

The antigen

WHAT DIOSYNVAX DOES

Engineered: a new backbone carrying conserved, protective epitopes.

WHY IT MATTERS

Immune focus shifts to features shared across the viral family.

↻   Flip back

3

Immune targets

WHAT MOST VACCINES DO

Usually one surface protein, eliciting antibodies to one target.

↻   Flip for the DIOSynVax approach

3

Immune targets

WHAT DIOSYNVAX DOES

Surface and internal proteins are engineered, engaging both humoral and cellular immunity.

WHY IT MATTERS

To escape, the virus must evade several responses at once.

↻   Flip back